Skip to content

Drug interactions

Methylprednisolone + Tucatinib

Severity: Moderate

Methylprednisolone and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib is a moderate CYP3A inhibitor and may increase methylprednisolone exposure. This could intensify corticosteroid adverse effects such as hyperglycemia, fluid retention and adrenal suppression.

What this interaction means in plain words

Methylprednisolone and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Methylprednisolone belongs to Endocrine; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Tucatinib inhibits CYP3A4, decreasing methylprednisolone metabolism.

What to do

Monitor for corticosteroid excess and reduce the methylprednisolone dose if needed, particularly with prolonged therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Methylprednisolone and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Methylprednisolone with Tucatinib?

MediHelp rates the interaction as moderate. Methylprednisolone and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib is a moderate CYP3A inhibitor and may increase methylprednisolone exposure. This could intensify corticosteroid adverse effects such as hyperglycemia, fluid retention and adrenal suppression.

How serious is the interaction between Methylprednisolone and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for corticosteroid excess and reduce the methylprednisolone dose if needed, particularly with prolonged therapy.

What other medicines interact with Methylprednisolone?

MediHelp also lists interactions of Methylprednisolone with, for example, Bcg vaccine live, Measles mumps and rubella vaccine live, Measles mumps rubella and varicella vaccine live. The full list is on the Methylprednisolone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in